FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Maria Fenyö

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Procedures

Neutralization Tests

Anatomy

Co-author Network

Publications

TOP 3
Gülşen Özkaya Şahin; Zacarias da Silva; Eva Maria Fenyö; Fredrik Månsson; Patrik Medstrand; Hans Norrgren; Angelica A Palm; Elzbieta Vincic; Marianne Jansson
Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.
Gülşen Özkaya Şahin; Peter Aaby; Zacarias da Silva; Eva Maria Fenyö; Birgitta Holmgren; Fredrik Månsson; Jens Nielsen; Hans Norrgren; Salma Nowroozalizadeh; Enas Sheik-Khalil; Marianne Jansson
Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.
Joakim Esbjörnsson; Eva Maria Fenyö; Per-Erik Isberg; Marianne Jansson; Anders Kvist; Fredrik Månsson; Antonio Biague; Zacarias J da Silva; Hans Norrgren; Salma Nowroozalizadeh; Patrik Medstrand
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Maria Fenyö (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gülşen Özkaya Şahin; Zacarias da Silva; Eva Maria Fenyö; Fredrik Månsson; Patrik Medstrand; Hans Norrgren; Angelica A Palm; Elzbieta Vincic; Marianne Jansson
Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.
AIDS research and human retroviruses 2013;29(3):470-8.
2013: Gülşen Özkaya Şahin; Peter Aaby; Zacarias da Silva; Eva Maria Fenyö; Birgitta Holmgren; Fredrik Månsson; Jens Nielsen; Hans Norrgren; Salma Nowroozalizadeh; Enas Sheik-Khalil; Marianne Jansson
Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.
Journal of virology 2013;87(1):273-81.
2012: Joakim Esbjörnsson; Eva Maria Fenyö; Per-Erik Isberg; Marianne Jansson; Anders Kvist; Fredrik Månsson; Antonio Biague; Zacarias J da Silva; Hans Norrgren; Salma Nowroozalizadeh; Patrik Medstrand
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
The New England journal of medicine 2012;367(3):224-32.
2011: Anna Tranell; Susanne Tingsborg; Eva Maria Fenyö; Stefan Schwartz
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm.
Virus research 2011;157(1):82-91.
2011: Marie Borggren; Melissa J Churchill; Eva Maria Fenyö; Paul R Gorry; Anders Karlsson; Johanna Repits; Jasminka Sterjovski; Hannes Uchtenhagen; Adnane Achour; Jan Albert; Marianne Jansson
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.
PloS one 2011;6(6):e20135.
2010: Anna Tranell; Eva Maria Fenyö; Stefan Schwartz
Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.
The Journal of biological chemistry 2010;285(41):31537-47.
2010: F Månsson; C Camara; A Biai; M Monteiro; Z J da Silva; Francisco Dias; A Alves; Sören Andersson; Eva Maria Fenyö; H Norrgren; M Unemo
High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa.
International journal of STD & AIDS 2010;21(9):631-5.
2010: Salma Nowroozalizadeh; Fredrik Månsson; Zacarias da Silva; Johanna Repits; Braima Dabo; Carla Pereira; Antonio Biague; Jan Albert; Jens Nielsen; Peter Aaby; Eva Maria Fenyö; Hans Norrgren; Birgitta Holmgren; Marianne Jansson
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
The Journal of infectious diseases 2010;201(8):1150-4.
2010: Mattias Mild; Anders Kvist; Joakim Esbjörnsson; Ingrid Karlsson; Eva Maria Fenyö; Patrik Medstrand
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2010;10(3):356-64.
2010: Gülşen Ozkaya Sahin; Emma J Bowles; Joe Parker; Hannes Uchtenhagen; Enas Sheik-Khalil; Stephen Taylor; Oliver G Pybus; Barbro Mäkitalo; Lilian Walther-Jallow; Mats Spångberg; Rigmor Thorstensson; Adnane Achour; Eva Maria Fenyö; Guillaume B E Stewart-Jones; Anna-Lena Spetz
Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.
PLoS pathogens 2010;6(9):e1001084.
2010: Joakim Esbjörnsson; Fredrik Månsson; Wilma Martínez-Arias; Elzbieta Vincic; Antonio Biague; Zacarias J da Silva; Eva Maria Fenyö; Hans Norrgren; Patrik Medstrand
Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.
Retrovirology 2010;7():23.
2009: Fredrik Månsson; Antonio Biague; Zacarias José da Silva; Francisco Dias; L A Fredrik Nilsson; Sören Andersson; Eva Maria Fenyö; Hans Norrgren
Prevalence and incidence of HIV-1 and HIV-2 before, during and after a civil war in an occupational cohort in Guinea-Bissau, West Africa.
AIDS (London, England) 2009;23(12):1575-82.
2009: Salma Nowroozalizadeh; Fredrik Månsson; Zacarias da Silva; Johanna Repits; Braima Dabo; Carla Pereira; Antonio Biague; Jan Albert; Jens Nielsen; Peter Aaby; Eva Maria Fenyö; Hans Norrgren; Birgitta Holmgren; Marianne Jansson
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections.
Cytokine 2009;46(3):325-31.
2009: Eva Maria Fenyö; Alan Heath; Stefania Dispinseri; Harvey Holmes; Paolo Lusso; Susan Zolla-Pazner; Helen Donners; Leo Heyndrickx; Jose Alcami; Vera Bongertz; Christian Jassoy; Mauro Malnati; David Montefiori; Christiane Moog; Lynn Morris; Saladin Osmanov; Victoria Polonis; Quentin Sattentau; Hanneke Schuitemaker; Ruengpung Sutthent; Terri Wrin; Gabriella Scarlatti
International network for comparison of HIV neutralization assays: the NeutNet report.
PloS one 2009;4(2):e4505.
2008: Johanna Repits; Jasminka Sterjovski; Daniel Badia-Martinez; Mattias Mild; Lachlan Gray; Melissa J Churchill; Damian F J Purcell; Anders Karlsson; Jan Albert; Eva Maria Fenyö; Adnane Achour; Paul R Gorry; Marianne Jansson
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
Virology 2008;379(1):125-34.
2008: Victoria R Polonis; Bruce K Brown; Andrew Rosa Borges; Susan Zolla-Pazner; Dimiter S Dimitrov; Mei-Yun Zhang; Susan W Barnett; Ruth Ruprecht; Gabriella Scarlatti; Eva Maria Fenyö; David C Montefiori; Francine E McCutchan; Nelson L Michael
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
Virology 2008;375(2):315-20.
2008: Salma Nowroozalizadeh; Marianne Jansson; Jenni Adamsson; Marianne Lindblad; Eva Maria Fenyö; Jan Holmgren; Ali M Harandi
Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera toxin.
Current HIV research 2008;6(3):230-8.
2008: Sisay A Abayneh; Peter Ellmark; Ulf Karlsson; Henrik Andersson; Carl A K Borrebaeck; Ingrid Karlsson; Eva Maria Fenyö
Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor use.
AIDS research and human retroviruses 2008;24(3):447-52.
2008: Peter Ellmark; Henrik Andersson; Sisay Abayneh; Eva Maria Fenyö; Carl A K Borrebaeck
Identification of a strongly activating human anti-CD40 antibody that suppresses HIV type 1 infection.
AIDS research and human retroviruses 2008;24(3):367-73.
2008: Mariangela Cavarelli; Ingrid Karlsson; Marisa Zanchetta; Liselotte Antonsson; Alessandro Plebani; Carlo Giaquinto; Eva Maria Fenyö; Anita De Rossi; Gabriella Scarlatti
HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.
PloS one 2008;3(9):e3292.
2007: Chiara Ripamonti; Thomas Leitner; Anna Laurén; Ingrid Karlsson; Angela Pastore; Mariangela Cavarelli; Liselotte Antonsson; Alessandro Plebani; Eva Maria Fenyö; Gabriella Scarlatti
Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression.
AIDS research and human retroviruses 2007;23(12):1531-40.
2007: Fredrik Månsson; Alfredo Alves; Zacarias José da Silva; Francisco Dias; Sören Andersson; Gunnel Biberfeld; Eva Maria Fenyö; Hans Norrgren
Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998 1999.
Sexually transmitted infections 2007;83(6):463-7.
2007: Mattias Mild; Joakim Esbjörnsson; Eva Maria Fenyö; Patrik Medstrand
Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
Journal of virology 2007;81(7):3369-76.
2007: Anna Laurén; Elzbieta Vincic; Hiroo Hoshino; Rigmor Thorstensson; Eva Maria Fenyö
CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
Retrovirology 2007;4():50.
2006: Ulrika E A Mårtensson; Eva Maria Fenyö; Björn Olde; Christer Owman
Characterization of the human chemerin receptor--ChemR23/CMKLR1--as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains.
Virology 2006;355(1):6-17.
2006: Mattias Mild; Asa Björndal; Patrik Medstrand; Eva Maria Fenyö
Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate.
Virology 2006;350(1):58-66.
2006: Anna Laurén; Rigmor Thorstensson; Eva Maria Fenyö
Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease.
The Journal of general virology 2006;87(Pt 3):595-606.
2006: Anna Laurén; Dalma Vödrös; Rigmor Thorstensson; Eva Maria Fenyö
Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome.
The Journal of general virology 2006;87(Pt 3):581-94.
2005: Charlotte Casper; Mattias Mild; Marianne Jansson; Anders Karlsson; Viveca Holmberg; Göran Bratt; Hubertus Van Paaschen; Peter Biberfeld; Asa Björndal; Jan Albert; Mikulas Popovic; Eva Maria Fenyö
Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets.
AIDS research and human retroviruses 2005;21(12):1003-10.
2005: Yu Shi; Eleonor Brandin; Elzbieta Vincic; Marianne Jansson; Anders Blaxhult; Katarina Gyllensten; Lars Moberg; Christina Broström; Eva Maria Fenyö; Jan Albert
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
The Journal of general virology 2005;86(Pt 12):3385-96.
2005: Johanna Repits; Monica Oberg; Joakim Esbjörnsson; Patrik Medstrand; Anders Karlsson; Jan Albert; Eva Maria Fenyö; Marianne Jansson
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.
The Journal of general virology 2005;86(Pt 10):2859-69.
2005: Ingrid Karlsson; Jean-Charles Grivel; Silvia Sihui Chen; Anders Karlsson; Jan Albert; Eva Maria Fenyö; Leonid B Margolis
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
Journal of virology 2005;79(17):11151-60.
2005: Peter Clevestig; Irina Maljkovic; Charlotte Casper; E Carlenor; Susanne Lindgren; Lars Navér; Ann-Britt Bohlin; Eva Maria Fenyö; Thomas Leitner; Anneka Ehrnst
The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission.
AIDS research and human retroviruses 2005;21(5):371-8.
2005: Dalma Vödrös; Eva Maria Fenyö
Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3) cell assay.
Methods in molecular biology (Clifton, N.J.) 2005;304():333-42.
2005: Anna Nordqvist; Eva Maria Fenyö
Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
Methods in molecular biology (Clifton, N.J.) 2005;304():273-85.
2004: Ingrid Karlsson; Liselotte Antonsson; Yu Shi; Monica Oberg; Anders Karlsson; Jan Albert; Björn Olde; Christer Owman; Marianne Jansson; Eva Maria Fenyö
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
Journal of virology 2004;78(21):11807-15.
2004: Dalma Vödrös; Eva Maria Fenyö
Primate models for human immunodeficiency virus infection. Evolution of receptor use during pathogenesis.
Acta microbiologica et immunologica Hungarica 2004;51(1-2):1-29.
2003: Ingrid Karlsson; Liselotte Antonsson; Yu Shi; Anders Karlsson; Jan Albert; Thomas Leitner; Björn Olde; Christer Owman; Eva Maria Fenyö
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
AIDS (London, England) 2003;17(18):2561-9.
2003: Dalma Vödrös; Rigmor Thorstensson; Robert W Doms; Eva Maria Fenyö; Jacqueline D Reeves
Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques.
Virology 2003;316(1):17-28.
2002: Charlotte Casper; Peter Clevestig; Elisabeth Carlenor; Thomas Leitner; Bo Anzén; Knut Lidman; Erik Belfrage; Jan Albert; Ann-Britt Bohlin; Lars Navér; Susanne Lindgren; Eva Maria Fenyö; Anneka Ehrnst
Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child.
The Journal of infectious diseases 2002;186(7):914-21.
2002: Y Shi; Jan Albert; G Francis; H Holmes; Eva Maria Fenyö
A new cell line-based neutralization assay for primary HIV type 1 isolates.
AIDS research and human retroviruses 2002;18(13):957-67.
2002: Charlotte Casper; Lars Navér; Peter Clevestig; Erik Belfrage; Thomas Leitner; Jan Albert; Susanne Lindgren; C Ottenblad; Ann-Britt Bohlin; Eva Maria Fenyö; Anneka Ehrnst
Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes.
AIDS research and human retroviruses 2002;18(5):343-52.
2001: Dalma Vödrös; Rigmor Thorstensson; Gunnel Biberfeld; D Schols; E De Clercq; Eva Maria Fenyö
Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally Infected with simian immunodeficiency virus (SIVsm).
Virology 2001;291(1):12-21.
2001: Dalma Vödrös; C Tscherning-Casper; L Navea; D Schols; E De Clercq; Eva Maria Fenyö
Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay.
Virology 2001;291(1):1-11.
2001: Charlotte Casper; Eva Maria Fenyö
Mother-to-child transmission of HIV-1: the role of HIV-1 variability and the placental barrier.
Acta microbiologica et immunologica Hungarica 2001;48(3-4):545-73.
2000: C Tscherning-Casper; Guillermina Dolcini; Philippe Mauclère; Eva Maria Fenyö; Françoise Barré-Sinoussi; Jan Albert; Elisabeth Menu
Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European Network on the Study of In Utero Transmission of HIV-1.
AIDS research and human retroviruses 2000;16(13):1313-8.
2000: AL Lawoko; B Johansson; J Ljunggren; A Fries; R Fredriksson; L Georgievska; B Malmvall; Rüdiger Pipkorn; Eva Maria Fenyö; Jonas Blomberg
Structural prerequisites for intersubtype B and D antigenicity of the third variable envelope region (V3) of human immunodeficiency virus type 1.
The Journal of infectious diseases 2000;182(1):49-58.
2000: C Tscherning-Casper; Dalma Vödrös; Elisabeth Menu; K Aperia; R Fredriksson; Guillermina Dolcini; Gérard Chaouat; Françoise Barré-Sinoussi; Jan Albert; Eva Maria Fenyö
Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2000;24(1):1-9.
2000: Eva Maria Fenyö
Biological phenotype and coreceptor usage of human immunodeficiency virus (a short review).
Acta microbiologica et immunologica Hungarica 2000;47(2-3):131-42.
1999: Marianne Jansson; E Backström; Asa Björndal; Viveca Holmberg; Paolo Rossi; Eva Maria Fenyö; M Popovic; Jan Albert; Hans Wigzell
Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
Journal of human virology 1999;2(6):325-38.
1999: C Tscherning-Casper; Nikos Papadogiannakis; M Anvret; L Stolpe; Susanne Lindgren; Ann-Britt Bohlin; Jan Albert; Eva Maria Fenyö
The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.
Journal of virology 1999;73(11):9673-8.
1999: AL Lawoko; B Johansson; Sandra Hjalmarsson; B Christensson; B Ljungberg; L Al-Khalili; M Sjölund; Rüdiger Pipkorn; Eva Maria Fenyö; Jonas Blomberg
Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
Journal of medical virology 1999;59(2):169-79.
1999: Asa Björndal; Anders Sönnerborg; C Tscherning; Jan Albert; Eva Maria Fenyö
Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients.
AIDS research and human retroviruses 1999;15(7):647-53.
1999: Andreas Mörner; Asa Björndal; Jan Albert; V N Kewalramani; Dan R Littman; R Inoue; Rigmor Thorstensson; Eva Maria Fenyö; Ewa Björling
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Journal of virology 1999;73(3):2343-9.
1998: Gary E Corrigan; L Al-Khalili; Anders Malmsten; Rigmor Thorstensson; Eva Maria Fenyö; Clas F R Källander; Jan Simon Gronowitz
Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains.
AIDS research and human retroviruses 1998;14(4):347-52.
1998: C Tscherning; A Alaeus; R Fredriksson; Asa Björndal; H Deng; Dan R Littman; Eva Maria Fenyö; Jan Albert
Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.
Virology 1998;241(2):181-8.
1997: Elisabeth Menu; B Mognetti; Marlène Moussa; V Nardese; L Tresoldi; C Tscherning; François-Xavier Mbopi-Keou; Sylvie Dubanchet; Philippe Mauclere; Eva Maria Fenyö; Gabriella Scarlatti; Françoise Barre-Sinoussi; Gérard Chaouat
Insights into the mechanisms of vertical transmission of HIV-1. BIOMED2 Working Group on the in utero transmission of HIV-1.
Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy 1997;3(4):245-58.
1997: YJ Zhang; R Fredriksson; J A McKeating; Eva Maria Fenyö
Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
Virology 1997;238(2):254-64.
1997: YJ Zhang; C Fracasso; J R Fiore; Asa Björndal; G Angarano; A Gringeri; Eva Maria Fenyö
Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors.
The Journal of infectious diseases 1997;176(5):1180-7.
1997: Gabriella Scarlatti; Eleonora Tresoldi; Asa Björndal; R Fredriksson; C Colognesi; H K Deng; Mauro S Malnati; Alessandro Plebani; Antonio G Siccardi; Dan R Littman; Eva Maria Fenyö; Paolo Lusso
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
Nature medicine 1997;3(11):1259-65.
1997: Asa Björndal; H Deng; Marianne Jansson; J R Fiore; C Colognesi; A Karlsson; Jan Albert; Gabriella Scarlatti; Dan R Littman; Eva Maria Fenyö
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
Journal of virology 1997;71(10):7478-87.
1997: J Kónya; G Stuber; Asa Björndal; Eva Maria Fenyö; J Dillner
Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the human immunodeficiency virus type 1 protease.
The Journal of general virology 1997;78 ( Pt 9)():2217-24.
1997: Y J Zhang; B Fadeel; V Hodara; Eva Maria Fenyö
Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cells.
AIDS (London, England) 1997;11(10):1219-25.
1997: J R Fiore; YJ Zhang; Asa Björndal; M Di Stefano; G Angarano; G Pastore; Eva Maria Fenyö
Biological correlates of HIV-1 heterosexual transmission.
AIDS (London, England) 1997;11(9):1089-94.
1997: JF Richmond; Farah Mustafa; Shan Lu; JC Santoro; J Weng; M O'Connell; Eva Maria Fenyö; J L Hurwitz; David C Montefiori; Harriet L Robinson
Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
Virology 1997;230(2):265-74.
1997: Farah Mustafa; JF Richmond; R Fernandez-Larsson; Shan Lu; R Fredriksson; Eva Maria Fenyö; M O'Connell; E Johnson; J Weng; JC Santoro; Harriet L Robinson
HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity.
Virology 1997;229(1):269-78.
1996: Eva Maria Fenyö; P Putkonen
Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections.
Immunology letters 1996;51(1-2):95-9.
1996: Gabriella Scarlatti; Thomas Leitner; V Hodara; Marianne Jansson; A Karlsson; J Wahlberg; P Rossi; M Uhlén; Eva Maria Fenyö; Jan Albert
Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS.
Immunology letters 1996;51(1-2):23-8.
1996: W Tan; Martin Schalling; C Zhao; M Luukkonen; M Nilsson; Eva Maria Fenyö; George Pavlakis; S Schwartz
Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.
Journal of virology 1996;70(6):3645-58.
1995: B G Luukkonen; W Tan; Eva Maria Fenyö; S Schwartz
Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system.
The Journal of general virology 1995;76 ( Pt 9)():2169-80.
1995: B G Luukkonen; Eva Maria Fenyö; S Schwartz
Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.
Virology 1995;206(2):854-65.
1995: Eva Maria Fenyö; C A Rosen
AIDS 1995. Virology: overview.
AIDS (London, England) 1995;9 Suppl A():S1-3.
1994: A Karlsson; K Parsmyr; K Aperia; Eric Sandström; Eva Maria Fenyö; Jan Albert
MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance.
The Journal of infectious diseases 1994;170(6):1367-75.
1994: Josè Ramòn Fiore; Asa Björndal; K A Peipke; M Di Stefano; G Angarano; G Pastore; H Gaines; Eva Maria Fenyö; Jan Albert
The biological phenotype of HIV-1 is usually retained during and after sexual transmission.
Virology 1994;204(1):297-303.
1994: A Valentin; Jan Albert; Eva Maria Fenyö; B Asjö
Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates.
Journal of virology 1994;68(10):6684-9.
1994: Eva Maria Fenyö
Antigenic variation of primate lentiviruses in humans and experimentally infected macaques.
Immunological reviews 1994;140():131-46.
1994: Y J Zhang; P Putkonen; Jan Albert; P Ohman; Gunnel Biberfeld; Eva Maria Fenyö
Stable biological and antigenic characteristics of HIV-2SBL6669 in nonpathogenic infection of macaques.
Virology 1994;200(2):583-9.
1994: A Karlsson; K Parsmyr; Eric Sandström; Eva Maria Fenyö; Jan Albert
MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
Journal of clinical microbiology 1994;32(2):364-70.
1993: Gabriella Scarlatti; V Hodara; P Rossi; L Muggiasca; Anna Maria Bucceri; Jan Albert; Eva Maria Fenyö
Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.
Virology 1993;197(2):624-9.
1993: Y J Zhang; P Ohman; P Putkonen; Jan Albert; L Walther; Per Stålhandske; Gunnel Biberfeld; Eva Maria Fenyö
Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis.
Virology 1993;197(2):609-15.
1993: Gabriella Scarlatti; Thomas Leitner; V Hodara; Eva Halapi; P Rossi; Jan Albert; Eva Maria Fenyö
Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1.
AIDS (London, England) 1993;7 Suppl 2():S45-8.
1993: Gabriella Scarlatti; Thomas Leitner; Eva Halapi; J Wahlberg; Marianne Jansson; Hans Wigzell; Eva Maria Fenyö; Jan Albert; M Uhlén; P Rossi
Analysis of the HIV-1 envelope V3-loop sequences from ten mother-child pairs.
Annals of the New York Academy of Sciences 1993;693():277-80.
1993: A Von Gegerfelt; C Diaz-Pohl; Eva Maria Fenyö; Kristina Broliden
Specificity of antibody-dependent cellular cytotoxicity in sera from human immunodeficiency virus type 2-infected individuals.
AIDS research and human retroviruses 1993;9(9):883-9.
1993: Gabriella Scarlatti; Jan Albert; P Rossi; V Hodara; P Biraghi; L Muggiasca; Eva Maria Fenyö
Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.
The Journal of infectious diseases 1993;168(1):207-10.
1993: Jan Albert; Ewa Björling; A von Gegerfelt; Gabriella Scarlatti; Y J Zhang; Eva Maria Fenyö; Rigmor Thorstensson
Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays.
AIDS research and human retroviruses 1993;9(6):501-4.
1993: W Tan; R Fredriksson; Asa Björndal; P Balfe; Eva Maria Fenyö
Cotransfection of HIV-1 molecular clones with restricted cell tropism may yield progeny virus with altered phenotype.
AIDS research and human retroviruses 1993;9(4):321-9.
1993: Gabriella Scarlatti; Thomas Leitner; Eva Halapi; J Wahlberg; Paola Marchisio; M A Clerici-Schoeller; Hans Wigzell; Eva Maria Fenyö; Jan Albert; M Uhlén
Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(5):1721-5.
1993: Ewa Björling; Gabriella Scarlatti; A von Gegerfelt; Jan Albert; Gunnel Biberfeld; Francesca Chiodi; E Norrby; Eva Maria Fenyö
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
Virology 1993;193(1):528-30.
1993: Josè Ramòn Fiore; Marianne Jansson; Gabriella Scarlatti; Gioacchino Angarano; S L Caputo; G Buccoliero; P Rossi; Eva Maria Fenyö; Giuseppe Pastore
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission.
AIDS (London, England) 1993;7(1):29-31.
1992: Francesca Chiodi; B Keys; Jan Albert; L Hagberg; J Lundeberg; M Uhlén; Eva Maria Fenyö; G Norkrans
Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.
Journal of clinical microbiology 1992;30(7):1768-71.
1992: A von Gegerfelt; Francesca Chiodi; B Keys; G Norkrans; L Hagberg; Eva Maria Fenyö; Kristina Broliden
Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals.
AIDS research and human retroviruses 1992;8(6):1133-8.
1992: P A Broliden; A von Gegerfelt; P Clapham; J Rosen; Eva Maria Fenyö; Britta Wahren; Kristina Broliden
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(2):461-5.
1991: J Wahlberg; Jan Albert; J Lundeberg; A Von Gegerfelt; Kristina Broliden; G Utter; Eva Maria Fenyö; M Uhlén
Analysis of the V3 loop in neutralization-resistant human immunodeficiency virus type 1 variants by direct solid-phase DNA sequencing.
AIDS research and human retroviruses 1991;7(12):983-90.
1991: A Von Gegerfelt; Jan Albert; L Morfeldt-Månson; Kristina Broliden; Eva Maria Fenyö
Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease.
Virology 1991;185(1):162-8.
1991: Gabriella Scarlatti; V Lombardi; A Plebani; Nicola Principi; Chiara Vegni; G Ferraris; Anna Maria Bucceri; Eva Maria Fenyö; Hans Wigzell; P Rossi
Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children.
AIDS (London, England) 1991;5(10):1173-8.
1991: C Orvell; Torsten Unge; Rama Bhikhabhai; Kristina Bäckbro; U Rudén; B Strandberg; Britta Wahren; Eva Maria Fenyö
Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodies.
The Journal of general virology 1991;72 ( Pt 8)():1913-8.
1991: D Böttiger; B Keys; P Putkonen; L Walther; Eva Maria Fenyö; E Norrby; B Oberg; Francesca Chiodi
Simian immunodeficiency virus (SIVsm) isolation from blood and brain of experimentally infected macaques.
AIDS (London, England) 1991;5(4):445-9.
1991: Francesca Chiodi; Eva Maria Fenyö
Neurotropism of human immunodeficiency virus.
Brain pathology (Zurich, Switzerland) 1991;1(3):185-91.
1991: R Fredriksson; P Stålhanske; A von Gegerfelt; B Lind; P Aman; E Rassart; Eva Maria Fenyö
Biological characterization of infectious molecular clones derived from a human immunodeficiency virus type-1 isolate with rapid/high replicative capacity.
Virology 1991;181(1):55-61.
1991: E Norrby; P Putkonen; Jan Albert; Eva Maria Fenyö
Immunodominant antigenic sites in primate immunodeficiency viruses and in vivo protection.
Biotechnology therapeutics 1991;2(1-2):21-9.
1990: Torsten Unge; H Ahola; Rama Bhikhabhai; Kristina Bäckbro; S Lövgren; Eva Maria Fenyö; Alik Honigman; Amos Panet; Jan Simon Gronowitz; B Strandberg
Expression, purification, and crystallization of the HIV-1 reverse transcriptase (RT).
AIDS research and human retroviruses 1990;6(11):1297-303.
1990: A Valentin; Jan Albert; Eva Maria Fenyö; B Asjö
HIV-1 infection of normal human macrophage cultures: implication for silent infection.
Virology 1990;177(2):790-4.
1990: Jan Albert; Eva Maria Fenyö
Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers.
Journal of clinical microbiology 1990;28(7):1560-4.
1990: S Schwartz; Barbara K Felber; D M Benko; Eva Maria Fenyö; G N Pavlakis
Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
Journal of virology 1990;64(6):2519-29.
1990: Jan Albert; Anders Nauclér; B Böttiger; P A Broliden; P Albino; S A Ouattara; C Björkegren; A Valentin; Gunnel Biberfeld; Eva Maria Fenyö
Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency.
AIDS (London, England) 1990;4(4):291-5.
1990: Jan Albert; B Abrahamsson; K Nagy; E Aurelius; Hans Gaines; G Nyström; Eva Maria Fenyö
Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.
AIDS (London, England) 1990;4(2):107-12.
1990: K Ljunggren; Viviana Moschese; P A Broliden; C Giaquinto; I Quinti; Eva Maria Fenyö; Britta Wahren; P Rossi; Mikael Jondal
Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
The Journal of infectious diseases 1990;161(2):198-202.
1989: K Ljunggren; Francesca Chiodi; P A Broliden; Jan Albert; G Norkrans; L Hagberg; Mikael Jondal; Eva Maria Fenyö
HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization.
AIDS research and human retroviruses 1989;5(6):629-38.
1989: Francesca Chiodi; A Valentin; B Keys; S Schwartz; B Asjö; Suzanne Gartner; M Popovic; Jan Albert; V A Sundqvist; Eva Maria Fenyö
Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid.
Virology 1989;173(1):178-87.
1989: V A Sundqvist; Jan Albert; E Ohlsson; Jorma Hinkula; Eva Maria Fenyö; Britta Wahren
Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
Journal of medical virology 1989;29(3):170-5.
1989: S Matsuda; Magnus Gidlund; Francesca Chiodi; Aurelio Aurelio Cafaro; A Nygren; B Morein; K Nilsson; Eva Maria Fenyö; Hans Wigzell
Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.
Scandinavian journal of immunology 1989;30(4):425-34.
1989: S Schwartz; Barbara K Felber; Eva Maria Fenyö; G N Pavlakis
Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(18):7200-3.
1989: K Ljunggren; Gunnel Biberfeld; Mikael Jondal; Eva Maria Fenyö
Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.
Journal of virology 1989;63(8):3376-81.
1989: K Ljunggren; A Karlson; Eva Maria Fenyö; Mikael Jondal
Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
Clinical and experimental immunology 1989;75(2):184-9.
1989: Eva Maria Fenyö; Jan Albert; B Asjö
Replicative capacity, cytopathic effect and cell tropism of HIV.
AIDS (London, England) 1989;3 Suppl 1():S5-12.
1988: Eva Maria Fenyö; L Morfeldt-Månson; Francesca Chiodi; B Lind; A von Gegerfelt; Jan Albert; E Olausson; B Asjö
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.
Journal of virology 1988;62(11):4414-9.
1988: Francesca Chiodi; Jan Albert; E Olausson; G Norkrans; L Hagberg; Anders Sönnerborg; B Asjö; Eva Maria Fenyö
Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection.
AIDS research and human retroviruses 1988;4(5):351-8.
1988: Francesca Chiodi; G Norkrans; L Hagberg; Anders Sönnerborg; Hans Gaines; S Frøland; Eva Maria Fenyö; E Norrby; B Vandvik
Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation.
Journal of the neurological sciences 1988;87(1):37-48.
1988: B Böttiger; K Ljunggren; A Karlsson; K Krohn; Eva Maria Fenyö; Mikael Jondal; Gunnel Biberfeld
Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
Clinical and experimental immunology 1988;73(3):339-42.
1988: J Kövamees; H Sheshberadaran; Francesca Chiodi; S Schwartz; C Orvell; Eva Maria Fenyö; E Norrby
Accentuated antibody response to paramyxoviruses in individuals infected with human immunodeficiency virus.
Journal of medical virology 1988;26(1):41-8.
1988: Francesca Chiodi; Anders Sönnerborg; Jan Albert; Hans Gaines; G Norkrans; L Hagberg; B Asjö; O Strannegård; Eva Maria Fenyö
Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions.
Journal of the neurological sciences 1988;85(3):245-57.
1988: Britta Wahren; Francesca Chiodi; K Ljunggren; S Putney; R Kurth; Robert C Gallo; Eva Maria Fenyö
B and T cell reactivities after immunization of macaques with HIV subcomponents.
AIDS research and human retroviruses 1988;4(3):199-210.
1988: Jan Albert; P O Pehrson; S Schulman; C Håkansson; G B Lövhagen; O Berglund; S Beckman; Eva Maria Fenyö
HIV isolation and antigen detection in infected individuals and their seronegative sexual partners.
AIDS (London, England) 1988;2(2):107-11.
1988: K Ljunggren; Francesca Chiodi; Gunnel Biberfeld; E Norrby; Mikael Jondal; Eva Maria Fenyö
Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(2):602-5.
1987: K Ljunggren; Eva Maria Fenyö; Gunnel Biberfeld; Mikael Jondal
Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro.
Journal of immunological methods 1987;104(1-2):7-14.
1987: K Ljunggren; B Böttiger; Gunnel Biberfeld; A Karlson; Eva Maria Fenyö; Mikael Jondal
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(7):2263-7.
1987: Hans Gaines; M von Sydow; Anders Sönnerborg; J Albert; J Czajkowski; P O Pehrson; Francesca Chiodi; L Moberg; Eva Maria Fenyö; B Asjö
Antibody response in primary human immunodeficiency virus infection.
Lancet 1987;1(8544):1249-53.
1987: F Chiodi; U Bredberg-Råden; Gunnel Biberfeld; B Böttiger; J Albert; B Asjö; Eva Maria Fenyö; E Norrby
Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study.
AIDS research and human retroviruses 1987;3(2):165-76.
1986: B Asjö; L Morfeldt-Månson; Jan Albert; Gunnel Biberfeld; A Karlsson; K Lidman; Eva Maria Fenyö
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
Lancet 1986;2(8508):660-2.
1985: B Asjö; L Morfeldt-Månson; Eva Maria Fenyö; B Böttiger; Gunnel Biberfeld; A Espmark
[LAV/HTLV-III--new discoveries on its properties, isolation, vaccination and therapy].
Läkartidningen 1985;82(20):1870-5.